Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients

Objectives: While recent studies have demonstrated several genetic alterations are associated with pathogenesis of RCC, the significance of cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase inhibitor 2B (CDKN2B) in tumorigenesis of RCC is less clear. We investigate the distri...

Full description

Bibliographic Details
Published in:	Practical Laboratory Medicine
Main Authors:	Nattaradee Kiatprungvech, Premsant Sangkum, Rozita Malinee, Suchada Sommaluan, Veerawat Korkiatsakul, Suchin Worawichawong, Budsaba Rerkamnuaychoke, Adcharee Kongruang, Suraida Aeesoa, Panuwat Lertsithichai, Kittinut Kijvikai, Wisoot Kongchareonsombat, Teerapong Siriboonpiputtana
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Renal cell carcinoma Clear-cell RCC CDKN2A and CDKN2B mutations MLPA
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352551724000568

Similar Items

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
by: E. Genescà, et al.
Published: (2018-07-01)

Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in blood vessels and cells in patients with carotid atherosclerosis
by: Yu. A. Koroleva, et al.
Published: (2020-11-01)

Polymorphism rs2383207 of CDKN2B-AS and Susceptibility to Atherosclerosis: A Mini Review
by: Sofia Vladimorovna Timofeeva, et al.
Published: (2022-11-01)

ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
by: Yahui Kong, et al.
Published: (2018-07-01)

A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia
by: Xiaoshan Hu, et al.
Published: (2024-12-01)

Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis
by: Nanamika Thakur, et al.
Published: (2021-01-01)

MAF1 represses CDKN1A through a Pol III-dependent mechanism
by: Yu-Ling Lee, et al.
Published: (2015-06-01)

Primary adrenocortical carcinoma with mutation in the CDKN2A gene
by: Changming Dong, et al.
Published: (2023-09-01)

<i>CDKN2A</i> Gene Mutations: Implications for Hereditary Cancer Syndromes
by: Anastasiia Danishevich, et al.
Published: (2023-12-01)

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report
by: Vallari Shah, et al.
Published: (2017-11-01)

<i>CDKN2A/B</i> Homozygous Deletions in Astrocytomas: A Literature Review
by: Alexander Yuile, et al.
Published: (2023-06-01)

Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
by: Liang Ma, et al.
Published: (2025-01-01)

CDKN2A Mutation: A Patient’s and Physician’s Experience
by: Yaelle Shaked, et al.
Published: (2025-02-01)

Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma
by: Hongbing Cheng, et al.
Published: (2025-01-01)

Genetic alterations of CDX1, CYLD and CDKN2B genes in CRC
by: Seyed Mohammad Taghi Hamidian, et al.
Published: (2021-09-01)

Cdkn1a silencing restores myoblast differentiation by inducing selective apoptosis in senescent cells
by: Sujin Kim, et al.
Published: (2025-04-01)

MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression
by: Yingrui Gu, et al.
Published: (2023-08-01)

A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
by: Maryam Aghasipour, et al.
Published: (2024-12-01)

Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma
by: Mengjie Tang, et al.
Published: (2024-02-01)

Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma
by: Alexander R. Kovach, et al.
Published: (2022-10-01)

Case report: Pilomatrix carcinoma with PDL1 expression and CDKN2A aberrant
by: Ayinuer Abula, et al.
Published: (2024-05-01)

Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer
by: Gao C, et al.
Published: (2023-12-01)

Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
by: Lucia Cottone, et al.
Published: (2020-04-01)

P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
by: Meenakshi Vij, et al.
Published: (2023-05-01)

The Association of SNPs Located in the CDKN2B-AS1 and LPA Genes With Carotid Artery Stenosis and Atherogenic Stroke
by: Anetta Lasek-Bal, et al.
Published: (2019-11-01)

CDKN2B-AS1 gene rs4977574 polymorphism in the severity of coronary artery disease in the Kazakh population
by: Askhat Myngbay, et al.
Published: (2023-12-01)

Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms
by: Hainan Li, et al.
Published: (2025-06-01)

Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression
by: Wei Liu, et al.
Published: (2020-12-01)

<a name="home"></a>The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma
by: J. Huber, et al.
Published: (2006-02-01)

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
by: Dimitrios Stefanoudakis, et al.
Published: (2024-03-01)

LncRNA-ANRIL regulates CDKN2A to promote malignant proliferation of Kasumi-1 cells
by: Jianxia Xu, et al.
Published: (2025-01-01)

Negative regulation of CDKN1A by the histone methyltransferase EHMT2 for cell growth in colorectal cancer
by: Kwangho Kim, et al.
Published: (2022-09-01)

Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma
by: Soha Karim, et al.
Published: (2025-08-01)

CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma
by: Federica Torricelli, et al.
Published: (2025-08-01)

Case report: The smallest 9p21.3 microdeletion involving CDKN2A but not CDKN2B causes multiple plexiform neurofibromas
by: Yuanyuan Zhang, et al.
Published: (2025-02-01)

Comprehensive analysis of prognosis and tumor immune microenvironment of cuproptosis-related gene CDKN2A in lung adenocarcinoma
by: Teng Song, et al.
Published: (2025-04-01)

The Tumor Suppressor Cdkn3 Is Required for Maintaining the Proper Number of Centrosomes by Regulating the Centrosomal Stability of Mps1
by: Vinayaka Srinivas, et al.
Published: (2015-11-01)

CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters
by: Fani Karagianni, et al.
Published: (2018-06-01)

CDKN2A-positive melanoma patient treated with combination immunotherapy – A case report
by: Katarina Zevnik, et al.
Published: (2022-07-01)

Use of GADD45A and CDKN1A Gene Expression Changes as Biomarker in Assessment of DNA Damage for Ionizing Radiation Exposure
by: Abdulsahib K. Ali, et al.
Published: (2014-12-01)